ABGSC acted as Joint Bookrunner in connection with the NOK 143 million private placement in Photocure ASA

On 27 April 2020, Photocure announced the successful allocation of ~2.2 million shares at a subscription price of NOK 65.50 per share, raising gross proceeds of approximately NOK 143 million.
The subscription price was determined through an accelerated bookbuilding process after close of trading on 27 April 2020. The Private Placement attracted very strong interest from existing shareholders, as well as from new high quality institutional investors. The transaction was multiple times oversubscribed.
The Company intends to use the net proceeds from the Private Placement to finance the acquisition of the Hexvix sales, marketing and distribution rights from Ipsen Pharma SAS.